Akero Therapeutics
(NASDAQ:AKRO)
$20.00
-0.51[-2.49%]
At close: Apr 19
$20.00
0[0.00%]
After Hours: 7:04AM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Akero Therapeutics Stock (NASDAQ:AKRO), Quotes and News Summary

Akero Therapeutics Stock (NASDAQ: AKRO) stock price, news, charts, stock research, profile.

Open$20.440
Close$20.760
Volume / Avg.789.143K / 1.371M
Day Range20.390 - 21.050
52 Wk Range11.250 - 58.380
Market Cap$1.379B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
33
Short Interest
11.62%
Days to Cover7.05

Recent News

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin.
Avi Kapoor
Akero Therapeutics' Stock Is Soaring Monday - Here's Why
Akero Therapeutics success in HARMONY Phase 2b study for efruxifermin. EFX demonstrated sustained efficacy and well-tolerance, marking a major milestone in liver disease treatment.
Vandana Singh
Super Micro Computer, Deckers Outdoor And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 50 points on Monday. Shares of Super Micro Computer, Inc. (NASDAQ: SMCI) rose sharply in today’s pre-market trading.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
3
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Akero Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercia...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
AKRO
TWST

FAQ

Q

How do I buy Akero Therapeutics (AKRO) stock?

A

You can purchase shares of Akero Therapeutics (NASDAQ: AKRO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Akero Therapeutics's (AKRO) competitors?

A

Other companies in Akero Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).

Q

What is the target price for Akero Therapeutics (AKRO) stock?

A

The latest price target for Akero Therapeutics (NASDAQ: AKRO) was reported by UBS on Tuesday, March 5, 2024. The analyst firm set a price target for 42.00 expecting AKRO to rise to within 12 months (a possible 110.00% upside). 18 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Akero Therapeutics (AKRO)?

A

The stock price for Akero Therapeutics (NASDAQ: AKRO) is $20 last updated Today at April 19, 2024 at 7:04 AM EDT.

Q

Does Akero Therapeutics (AKRO) pay a dividend?

A

There are no upcoming dividends for Akero Therapeutics.

Q

When is Akero Therapeutics (NASDAQ:AKRO) reporting earnings?

A

Akero Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is Akero Therapeutics (AKRO) going to split?

A

There is no upcoming split for Akero Therapeutics.

Q

What sector and industry does Akero Therapeutics (AKRO) operate in?

A

Akero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch